Clinical Trials
5 trialsNCT02684292 2026-02-18
MK-3475-204
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03598608 2026-02-05
MK-4280-003
Merck Sharp & Dohme LLC
Phase 1/2 Completed
NCT05508867 2026-01-20
MK-4280A-008
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT03010176 2025-10-29
MK-1454-001
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT04317066 2025-04-06
KEYNOTE-A33
Merck Sharp & Dohme LLC
Phase 1 Completed